2 Articles by David Erritzoe
Neuroplasticity and Psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.
Neuroscience and biobehavioral reviews – April 02, 2025
Summary
Psychedelics may reshape our understanding of brain health, showing promise in treating mood disorders by enhancing functional and structural neuroplasticity. Research indicates these compounds boost the nervous system's adaptability, fostering long-term changes that could revolutionize therapeutic approaches. Exciting advancements in imaging techniques are paving the way for deeper insights into their potential.
Abstract
Neuroplasticity, the ability of the nervous system to adapt throughout an organism's lifespan, offers potential as both a biomarker and treatment t...
Psychedelics and Suicide-Related Outcomes: A Systematic Review.
Journal of clinical medicine – February 20, 2025
Summary
Suicide is a leading cause of death globally, emphasizing the urgent need for effective treatments. Recent findings suggest that psychedelics like psilocybin and MDMA may significantly reduce suicidal thoughts in individuals with mood and psychiatric disorders. Studies indicate notable improvements in suicidal ideation, showcasing the potential of these therapies for enhancing mental health outcomes.
Abstract
Background/Objectives: Suicide accounts for 1.4% of global deaths, and the slow-acting nature of traditional treatments for suicide risk underscore...